Patent ID: 8426369

Claim:
A chemotherapeutic compound having a structure according to Formula I: wherein X is selected from the group consisting of cis and trans ethylenyl; R 1 and R 2 are independently selected from the group consisting of C 1 -C 3 alkyls and OR 4 , wherein R 4 is selected from the group consisting of hydrogen and C 1 -C 3 alkyls; and R 3 is selected from the group consisting of halogens, glucose, C 1 -C 3 alkyls, NO 2 , H 2 PO 4 , SO 2 R 4 , SR 4 , COOR 4 , COR 4 , NR 5 R 6 and COR 7 , wherein R 4 , R 5 , and R 6 are independently selected from the group consisting of hydrogen and C 1 -C 3 alkyls; and R 7 is NR 8 R 9 , wherein R 8 and R 9 are independently selected from the group consisting of hydrogen and C 1 -C 3 alkyls; with the proviso that X, R 1 , R 2 and R 3 may not be selected so that formula I is resveratrol or pterostilbene.